Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2014Journal of Clinical OncologyOpen Access

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

Carsten Denkert
Carsten DenkertUniversité Paris-Sud
Gϋnter von Minckwitz
Gϋnter von MinckwitzNorthwestern UniversityJBJan C. BraseNovartis (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Denkert et al. (2014) studied this question.

synapsesocial.com/papers/6a0cc6736d2ea0967e4a451dhttps://doi.org/10.1200/jco.2014.58.1967
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer2012 · 273 citations
  2. 2Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)2005 · 2,134 citations
  3. 3<i>In Situ</i> Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas2014 · 447 citations
  4. 4A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors2012 · 265 citations
  5. 5Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis2012 · 220 citations